- Home
- NGEN vs RGCO Comparison
NGEN vs RGCO Comparison
Compare NGEN & RGCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | NGEN | RGCO |
|---|---|---|
| Founded | 2017 | 1912 |
| Country | Canada | United States |
| Employees | N/A | 106 |
| Industry | | Oil & Gas Production |
| Sector | | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 208.6M | 225.0M |
| IPO Year | 2018 | 2005 |
Fundamental Metrics
Financial Performance| Metric | NGEN | RGCO |
|---|---|---|
| Price | $1.76 | $21.10 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $11.08 | N/A |
| AVG Volume (30 Days) | ★ 454.0K | 9.4K |
| Earning Date | 11-14-2026 | 11-18-2026 |
| Dividend Yield | N/A | ★ 4.09% |
| EPS Growth | N/A | ★ 11.21 |
| EPS | N/A | ★ 1.37 |
| Revenue | N/A | ★ $95,334,212.00 |
| Revenue This Year | N/A | $15.70 |
| Revenue Next Year | N/A | $4.44 |
| P/E Ratio | ★ N/A | $15.72 |
| Revenue Growth | N/A | ★ 12.63 |
| 52 Week Low | $1.58 | $20.55 |
| 52 Week High | $5.93 | $27.17 |
Technical Indicators
Market Signals| Indicator | NGEN | RGCO |
|---|---|---|
| Relative Strength Index (RSI) | 40.39 | N/A |
| Support Level | $1.85 | N/A |
| Resistance Level | $2.32 | N/A |
| Average True Range (ATR) | 0.12 | 0.00 |
| MACD | -0.04 | 0.00 |
| Stochastic Oscillator | 4.08 | 0.00 |
Price Performance
Historical ComparisonAbout NGEN NervGen Pharma Corp. Common stock
NervGen Pharma Corp is a clinical-stage biopharmaceutical company developing first-in-class neuroreparative therapeutics for spinal cord injury and other traumatic and neurologic conditions. The Company's principal business activity is the discovery, development and commercialization of neuroreparative therapeutics for spinal cord injury (SCI) and other neurotraumatic and neurologic conditions. NervGen's initial target indication is SCI. The company's pipeline products include NVG-291 and NVG-300.
About RGCO RGC Resources Inc.
RGC Resources Inc is involved in the business of distribution and sale of natural gas to residential, commercial, and industrial customers within its service territory in Roanoke, Virginia, and its surrounding localities. The company also provides certain non-regulated services. The company relies on multiple interstate pipelines to transport natural gas. The company operates in three segments: Gas Utility, which is the key revenue generator; Investment in Affiliates this segment reflects the income generated through the activities of the Company's investment in MVP and Southgate projects and Parent & Other including the unregulated activities of the Company as well as certain corporate eliminations.